Strides Pharma

Strides Pharma receives Form 483 with four procedural observations following routine USFDA inspection at US facility

Strides Pharma shares surge over 6% as Q4 revenue rises 17% YoY to Rs 1,190.4 crore

Strides Pharma receives USFDA approval for Celecoxib Capsules

Strides Pharma incorporates new subsidiary ‘Pivot Path’ to boost life sciences and digital innovation

Strides Pharma shares surge 5% as revenue jumps 15% YoY in Q3 FY25

Strides Pharma Q3 FY25 Results: Revenue up 15% YoY to Rs 1,154 crore, Net Profit up 60% YoY

Strides Pharma receives USFDA approval for acetaminophen and ibuprofen tablets, expanding OTC portfolio

Strides Pharma shares surge 3% on USFDA nod for Fluoxetine Tabs 60 mg

Strides Pharma gets USFDA approval for Fluoxetine Tabs 60 mg

Strides Pharma secures approval for OneSource, India’s first specialty pharma CDMO

Strides Pharma Science shares at 9-year high after US subsidiary closure

Strides Pharma Science Ltd.'s shares surged to a nearly nine-year high on Friday, following the company's decision to cease operations of its US subsidiary, Altima Innovations Inc.

Adani Power, Vodafone Idea, Indigo, and others are among stocks to keep an eye on

As they release their June quarter profits today, Adani Total Gas, Adani Enterprise, Britannia Industries, Berger Paints, Dabur India, and BEML will be scrutinised.